ConcertAI’s TeraRecon and Avicenna.AI Partner on AI for Detection of Incidental PE

March 13, 2023—ConcertAI’s TeraRecon, a company focused on advanced visualization and artificial intelligence (AI) clinical software-as-a-service, announced a partnership to offer medical imaging AI specialist Avicenna.AI’s Cina-iPE solution for detecting the presence of incidental pulmonary embolisms (iPE) as part of TeraRecon’s Eureka clinical AI solution.

According to the ConcertAI press release, Cina-iPE is a CE Mark-approved AI tool that analyzes images from CT scans and detects the presence of iPE immediately and with consistency and accuracy. The TeraRecon Eureka clinical AI and intuition software are KLAS top-rated solutions for clinical AI and advanced visualization.

As noted by the company, iPE is a frequent finding on routine CT scans of the chest, but only 25% of incidental emboli are reported at the initial interpretation. Delayed and missed findings are some of the most serious problems in diagnostic imaging, and iPE is a significant cause of mortality in the cancer patient population.

As noted in the press release, Avicenna.AI’s solutions for health care use deep learning to identify, detect, and quantify life-threatening pathologies from CT medical images. The company’s solutions automatically detect and prioritize emergency cases within seconds, assess them for severity, and then alert radiologists.

The TeraRecon Eureka clinical AI is open to third-party AI algorithms, allowing consolidated management of all AI interpretation solutions with seamless integrations of PACS—picture archiving and communication systems. Multispecialty care teams can see results and receive mobile alerts to confirm AI findings, ensuring optimal and timely patient interventions, management, and coordinated care delivery.